Fig 1.
Policy enabling inpatient needle and syringe distribution at Saint John Regional Hospital during the study period.
Table 1.
Descriptive characteristics of patients during first episode of injection drug use-associated infective endocarditis in Halifax and Saint John, October 2015-March 2017.
Fig 2.
Access to and uptake of opioid agonist treatment during hospitalizations for injection drug use-associated infective endocarditis in Halifax, Nova Scotia (n = 14 hospitalizations), and Saint John, New Brunswick (n = six hospitalizations), October 2015-March 2017.
Vertical bars represent proportion of patients with IDU-IE and untreated opioid use disorder at each site; numbers within bars represent the number of patients in each category at each site. IDU-IE: Injection drug use-associated infective endocarditis. OAT: Opioid agonist treatment.
Table 2.
Frequency of documentation of potential unmet care needs related to substance use and addiction among patients hospitalized with injection drug use-associated infective endocarditis in Halifax, Nova Scotia and Saint John, New Brunswick, Canada.